Global Prenatal Diagnostics Market Overview:
Global Prenatal Diagnostics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Prenatal Diagnostics Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Prenatal Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Prenatal Diagnostics Market:
The Prenatal Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Prenatal Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Prenatal Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Prenatal Diagnostics market has been segmented into:
Non-Invasive
Invasive
By Application, Prenatal Diagnostics market has been segmented into:
Trisomy
Micro-Deletions Symptoms
Other Applications
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Prenatal Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Prenatal Diagnostics market.
Top Key Players Covered in Prenatal Diagnostics market are:
ANGLE Plc
Berry Genomics Co. Ltd.
BGI Genomics
F. Hoffmann-La Roche Ltd.
Hologic Inc.
Illumina Inc.
Laboratory Corporation of America® Holdings
Lifecodexx AG
Natera Inc.
Quest Diagnostics Inc.
Ravgen Inc.
Sequenom Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Prenatal Diagnostics Market Type
4.1 Prenatal Diagnostics Market Snapshot and Growth Engine
4.2 Prenatal Diagnostics Market Overview
4.3 Non-Invasive
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Non-Invasive: Geographic Segmentation Analysis
4.4 Invasive
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Invasive: Geographic Segmentation Analysis
Chapter 5: Prenatal Diagnostics Market Application
5.1 Prenatal Diagnostics Market Snapshot and Growth Engine
5.2 Prenatal Diagnostics Market Overview
5.3 Trisomy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Trisomy: Geographic Segmentation Analysis
5.4 Micro-Deletions Symptoms
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Micro-Deletions Symptoms: Geographic Segmentation Analysis
5.5 Other Applications
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Other Applications: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Prenatal Diagnostics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ANGLE PLC; BERRY GENOMICS CO. LTD.; BGI GENOMICS; F. HOFFMANN-LA ROCHE LTD.; HOLOGIC INC.; ILLUMINA INC.; LABORATORY CORPORATION OF AMERICA® HOLDINGS; LIFECODEXX AG; NATERA INC.; QUEST DIAGNOSTICS INC.; RAVGEN INC.; SEQUENOM INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
Chapter 7: Global Prenatal Diagnostics Market By Region
7.1 Overview
7.2. North America Prenatal Diagnostics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Non-Invasive
7.2.2.2 Invasive
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Trisomy
7.2.3.2 Micro-Deletions Symptoms
7.2.3.3 Other Applications
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Prenatal Diagnostics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Non-Invasive
7.3.2.2 Invasive
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Trisomy
7.3.3.2 Micro-Deletions Symptoms
7.3.3.3 Other Applications
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Prenatal Diagnostics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Non-Invasive
7.4.2.2 Invasive
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Trisomy
7.4.3.2 Micro-Deletions Symptoms
7.4.3.3 Other Applications
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Prenatal Diagnostics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Non-Invasive
7.5.2.2 Invasive
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Trisomy
7.5.3.2 Micro-Deletions Symptoms
7.5.3.3 Other Applications
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Prenatal Diagnostics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Non-Invasive
7.6.2.2 Invasive
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Trisomy
7.6.3.2 Micro-Deletions Symptoms
7.6.3.3 Other Applications
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Prenatal Diagnostics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Non-Invasive
7.7.2.2 Invasive
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Trisomy
7.7.3.2 Micro-Deletions Symptoms
7.7.3.3 Other Applications
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Prenatal Diagnostics Scope:
|
Report Data
|
Prenatal Diagnostics Market
|
|
Prenatal Diagnostics Market Size in 2025
|
USD XX million
|
|
Prenatal Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Prenatal Diagnostics Base Year
|
2024
|
|
Prenatal Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
ANGLE Plc, Berry Genomics Co. Ltd., BGI Genomics, F. Hoffmann-La Roche Ltd., Hologic Inc., Illumina Inc., Laboratory Corporation of America® Holdings, Lifecodexx AG, Natera Inc., Quest Diagnostics Inc., Ravgen Inc., Sequenom Inc..
|
|
Key Segments
|
By Type
Non-Invasive
Invasive
By Applications
Trisomy
Micro-Deletions Symptoms
Other Applications
|
